Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;22(4):350-358.
doi: 10.14701/ahbps.2018.22.4.350. Epub 2018 Nov 27.

Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma

Affiliations

Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma

YouJin Lee et al. Ann Hepatobiliary Pancreat Surg. 2018 Nov.

Abstract

Backgrounds/aims: Several studies report worse prognosis after left-side compared to right-side liver resection in patients with perihilar cholangiocarcinoma. In this study, we compared outcomes of left-side and right-side resections for Bismuth type III hilar cholangiocarcinoma and analyzed factors affecting survival.

Methods: From May 1995 to December 2012, 179 patients underwent surgery at Samsung Medical Center for type III hilar cholangiocarcinoma. Among these patients, 138 received hepatectomies for adenocarcinoma with curative intent: 103 had right-side resections (IIIa group) and 35 had left-side resections (IIIb group). Perioperative demographics, morbidity, mortality, and overall and disease-free survival rates were compared between the groups.

Results: BMI was higher in the IIIa group (24±2.6 kg/m2 versus 22.7±2.8 kg/m2; p=0.012). Preoperative portal vein embolization was done in 23.3% of patients in the IIIa group and none in the IIIb group. R0 rate was 82.5% in the IIIa group and 85.7% in the IIIb group (p=0.796) and 3a complications by Clavien-Dindo classification were significantly different between groups (10.7% for IIIa versus 23.3% for IIIb; p=0.002). The 5-year overall survival rate was 33% in the IIIa group and 35% in the IIIb group (p=0.983). The 5-year disease-free survival rate was 28% in the IIIa group and 29% in the IIIb group (p=0.706). Advanced T-stages 3 and 4 and LN metastasis were independent prognostic factors for survival and recurrence by multivariate analysis.

Conclusions: No significant differences were seen in outcomes by lesion side in patients receiving curative surgery for Bismuth type III hilar cholangiocarcinoma.

Keywords: Hilar cholangiocarcinoma; Klatskin tumor; Left hepatectomy; R0 resection; Right hepatectomy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Flowchart of patients.
Fig. 2
Fig. 2. Survival analysis for all patients. (A) Overall survival, (B) Disease-free survival.
Fig. 3
Fig. 3. Comparison of outcomes between IIIa and IIIb. (A) Overall survival, (B) Disease-free survival.
Fig. 4
Fig. 4. Comparison of outcomes between extended hepatectomy with caudate lobectomy and simple hepatectomy without caudate lobectomy. (A) Overall survival, (B) Disease-free survival.
Fig. 5
Fig. 5. Comparison of outcomes between R0 resection and R1 or R2 resection. (A) Overall survival, (B) disease-free survival.

References

    1. Soares KC, Kamel I, Cosgrove DP, Herman JM, Pawlik TM. Hilar cholangiocarcinoma: diagnosis, treatment options, and management. Hepatobiliary Surg Nutr. 2014;3:18–34. - PMC - PubMed
    1. Klatskin G. Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med. 1965;38:241–256. - PubMed
    1. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obstet. 1975;140:170–178. - PubMed
    1. Tompkins RK, Thomas D, Wile A, Longmire WP., Jr Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg. 1981;194:447–457. - PMC - PubMed
    1. Blumgart LH, Hadjis NS, Benjamin IS, Beazley R. Surgical approaches to cholangiocarcinoma at confluence of hepatic ducts. Lancet. 1984;1:66–70. - PubMed

LinkOut - more resources